BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2235171)

  • 1. Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children.
    Vadheim CM; Greenberg DP; Marcy SM; Froeschle J; Ward JI
    Pediatr Infect Dis J; 1990 Aug; 9(8):555-61. PubMed ID: 2235171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of Haemophilus influenzae B-diphtheria conjugate vaccination in German children].
    Zielen S; Scheurer J; Rhodius U; Schäfer V; Isenberg H; Bauscher P; Schröder S; Ahrens P; Hofmann D
    Monatsschr Kinderheilkd; 1992 Dec; 140(12):852-6. PubMed ID: 1491705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Haemophilus influenzae type b vaccines.
    Stieb DM; Frayha HH; Oxman AD; Shannon HS; Hutchison BG; Crombie FS
    CMAJ; 1990 Apr; 142(7):719-33. PubMed ID: 2107962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR
    Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group.
    Vadheim CM; Greenberg DP; Partridge S; Jing J; Ward JI
    Pediatrics; 1993 Aug; 92(2):272-9. PubMed ID: 8337029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.
    Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI
    JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
    Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age.
    Hay JW; Daum RS
    Pediatr Infect Dis J; 1990 Apr; 9(4):246-52. PubMed ID: 2110651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
    Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
    J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
    Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
    Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
    Black SB; Shinefield HR; Fireman B; Hiatt R
    J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
    Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
    Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.
    Berkowitz CD; Ward JI; Meier K; Hendley JO; Brunell PA; Barkin RA; Zahradnik JM; Samuelson J; Gordon L
    J Pediatr; 1987 Apr; 110(4):509-14. PubMed ID: 3550021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.